Lightning Talk - Device Circularity

Lightning Talk - Device Circularity

Thursday, January 25, 2024 10:25 AM to 10:37 AM · 12 min. (Africa/Abidjan)
Conference Room 721
Conference
Sustainability

Information

Learnings and experiences with establishing Takeback and Recycling systems for medical devices will be presented during this session, with a focus on regulatory, logistical and technical challenges and how to overcome them.

Frode will also zoom in on the value of recycling and how to use the learnings to shape a different future addressing the way we use our resources and creating business around recycling.

SCHOTTSCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world - because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 16 manufacturing sites in Europe, North and South America, and Asia. With over 1,000 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, and around 130 employees in R&D, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030.

Log in

See all the content and easy-to-use features by logging in or registering!